{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:26:08Z","timestamp":1789244768795,"version":"build-2803163510"},"reference-count":164,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease characterized by immune-mediated destruction of intrahepatic bile ducts. This review synthesizes current knowledge on the critical role of innate immunity, specifically involving cholangiocytes, bile components, and associated immune cells. Cholangiocytes function not only as passive targets but also as active immunomodulators through mechanisms including Toll-like receptor (TLR) signaling, antigen presentation, and immune cell recruitment. Dysregulated bile acid signaling via receptors like TGR5 disrupts immune homeostasis, while apoptosis of biliary epithelial cells releases antigens (e.g., PDC-E2), triggering aberrant innate and adaptive immune responses. Innate lymphoid cells (ILCs), natural killer (NK) cells, and macrophages exhibit altered frequencies and functions in PBC, driving chronic inflammation and fibrosis through cytokine cascades (e.g., IL-17, IFN\u03b3) and interactions within the gut-liver axis. Furthermore, biliary microbiota dysbiosis exacerbates disease by promoting bacterial translocation, modifying bile acid metabolism, and activating innate immune pathways. Current clinical management with ursodeoxycholic acid (UDCA) and obeticholic acid (OCA) primarily addresses cholestasis. However, the immunomodulatory effects of these agents remain constrained. Targeted therapeutic strategies addressing innate immune pathways\u2014exemplified by RIPK2 (Receptor Interacting Serine\/Threonine Kinase 2) inhibition, IL-1 blockade(Canakinumab), and T cell immunoglobulin mucin domain-containing protein 3 (TIM-3) modulation\u2014alongside cell-based interventions such as mesenchymal stem cell therapy, demonstrate considerable therapeutic potential. Advancing these modalities necessitates multidisciplinary integration to facilitate clinical translation. Additionally, Prognostic indices like the neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) reflect systemic inflammation and correlate with disease progression. Achieving therapeutic precision requires deeper elucidation of the gut-biliary-immune axis, trained immunity mechanisms, and cholangiocyte senescence, paving the way for targeted interventions in PBC. Establishing a comprehensive treatment burden assessment system is imperative to facilitate the transition from investigational platforms to clinical care.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1655287","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:30:44Z","timestamp":1759383044000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Innate immunity of bile and cholangiocytes in primary biliary cholangitis"],"prefix":"10.3389","volume":"16","author":[{"given":"Ran","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061288","article-title":"Primary biliary cholangitis and primary sclerosing cholangitis: current knowledge of pathogenesis and therapeutics","volume":"10","author":"Park","year":"2022","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14656566.2025.2516622","article-title":"Advancing care in primary biliary cholangitis: emerging insights and novel therapies","volume":"16","author":"V\u00f6gelin","year":"2025","journal-title":"Expert Opin Pharmacother"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2023.21768","article-title":"Diagnostic and prognostic value of monocyte-to-lymphocyte ratio and red cell distribution width to lymphocyte ratio in primary biliary cholangitis","volume":"34","author":"Jiang","year":"2023","journal-title":"Turk J Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00347","article-title":"Chinese society of hepatology, chinese medical association. Guidelines on the diagnosis and management of primary biliary cholangitis (2021)","volume":"11","author":"You","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23438","article-title":"Autotaxin: A Potential biomarker for primary biliary cholangitis","volume":"10","author":"Yang","year":"2023","journal-title":"Heliyon"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31810","article-title":"Accuracy of transient elastography in assessing fibrosis at diagnosis in na\u00efve patients with primary biliary cholangitis: A dual cut-off approach","volume":"74","author":"Cristoferi","year":"2021","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230174","article-title":"Imaging of biliary tree abnormalities","volume":"44","author":"Lopes Vendrami","year":"2024","journal-title":"Radiographics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31776","article-title":"Male sex is associated with higher rates of liver-related mortality in primary biliary cholangitis and cirrhosis","volume":"74","author":"John","year":"2021","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5152\/tjg.2023.22239","article-title":"Management of primary biliary cholangitis: current treatment and future perspectives","volume":"34","author":"Barba Bernal","year":"2023","journal-title":"Turk J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.05.010","article-title":"Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation","volume":"81","author":"Montano-Loza","year":"2024","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13584","article-title":"The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis","volume":"51","author":"Kawata","year":"2021","journal-title":"Hepatol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101168","article-title":"Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis","volume":"6","author":"Roberts","year":"2024","journal-title":"JHEP Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5009\/gnl220420","article-title":"Clinical outcomes and validation of ursodeoxycholic acid response scores in patients with korean primary biliary cholangitis: A multicenter cohort study","volume":"17","author":"Chang","year":"2023","journal-title":"Gut Liver"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.12.010","article-title":"Treatment response to ursodeoxycholic acid in primary biliary cholangitis: A systematic review and meta-analysis","volume":"55","author":"Gazda","year":"2023","journal-title":"Dig Liver Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002216","article-title":"Simplified 6-month prediction scores for primary biliary cholangitis patients treated with ursodeoxycholic acid","volume":"34","author":"Pinyopornpanish","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2022.06.005","article-title":"Prognostic scoring systems in primary biliary cholangitis: an update","volume":"26","author":"Scaravaglio","year":"2022","journal-title":"Clin Liver Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15289","article-title":"Portal pressure is of significant prognostic value in primary biliary cholangitis","volume":"43","author":"Warnes","year":"2023","journal-title":"Liver Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","article-title":"Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease","volume":"18","author":"Horst","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.08.019","article-title":"How the biliary tree maintains immune tolerance","volume":"1864","author":"Zhang","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866040","article-title":"Role of immune cells in biliary repair","volume":"13","author":"Lan","year":"2022","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.10.035","article-title":"IL-17A\/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression","volume":"74","author":"Stein","year":"2021","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940688","article-title":"Peroxisome proliferator-activated receptors regulate hepatic immunity and assist in the treatment of primary biliary cholangitis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14066","article-title":"TCR\u03b2 repertoire of memory T cell reveals potential role for Escherichia coli in the pathogenesis of primary biliary cholangitis","volume":"39","author":"Hou","year":"2019","journal-title":"Liver Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000452300","article-title":"Bile acids and the potential role in primary biliary cirrhosis","volume":"94","author":"Yang","year":"2016","journal-title":"Digestion"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01852","article-title":"The critical role of chemokine (C-C motif) receptor 2-positive monocytes in autoimmune cholangitis","volume":"9","author":"Reuveni","year":"2018","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.05.014","article-title":"Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis","volume":"167","author":"Wang","year":"2024","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.06.037","article-title":"B cells drive CCR5+CD4+ tissue-resident memory T cell cytotoxicity via IL-15R\u03b1-IL-15 signaling in primary biliary cholangitis","author":"Pu","year":"2025","journal-title":"J Hepatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform(GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15961","article-title":"Conventional type 1 dendritic cells are essential for the development of primary biliary cholangitis","volume":"44","author":"Reuveni","year":"2024","journal-title":"Liver Int"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.08.021","article-title":"Bile acid receptors in the biliary tree: TGR5 in physiology and disease","volume":"1864","author":"Deutschmann","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1556\/1886.2021.00023","article-title":"Importance of cortactin for efficient epithelial NF-\u0138B activation by Helicobacter pylori, Salmonella enterica and Pseudomonas aeruginosa, but not Campylobacter spp","volume":"11","author":"Tegtmeyer","year":"2022","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.23812\/20-80-A-29","article-title":"Chlamydia trachomatis elicits TLR3 expression but disrupts the inflammatory signaling down-modulating NF\u03baB and IRF3 transcription factors in human Sertoli cells","volume":"34","author":"Di Pietro","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00130-21","article-title":"Human nasal and lung tissues infected ex vivo with SARS-coV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract","volume":"95","author":"Alfi","year":"2021","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022643118","article-title":"SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes","volume":"118","author":"Li","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/ijms22010208","article-title":"IFN\u03b3 is A key link between obesity and th1-mediated autoimmune diseases","volume":"22","author":"Bae","year":"2020","journal-title":"Int J OF Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.875593","article-title":"Reduced peroxisome proliferator-activated receptor-\u03b1 and bile acid nuclear receptor NR1H4\/FXR may affect the hepatic immune microenvironment of biliary atresia","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052645","article-title":"Loss of Nckx3 Exacerbates Experimental DSS-Induced Colitis in Mice through p53\/NF-\u03baB Pathway","volume":"22","author":"Tran","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.chom.2022.08.004","article-title":"Gut commensal E. coli outer membrane proteins activate the host food digestive system through neural-immune communication","volume":"30","author":"Geng","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2023.08.008","article-title":"Multifaceted role of CD14 in innate immunity and tissue homeostasis","volume":"74","author":"Na","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111754","article-title":"The pathogenesis, models and therapeutic advances of primary biliary cholangitis","volume":"140","author":"Li","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B42","doi-asserted-by":"publisher","first-page":"12584","DOI":"10.1038\/s41598-020-69358-4","article-title":"Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis","volume":"10","author":"Jang","year":"2020","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J Hepatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"11413","DOI":"10.1038\/s41598-021-91016-6","article-title":"Interferon-induced protein with tetratricopeptide repeats 3 may be a key factor in primary biliary cholangitis","volume":"11","author":"Sasaki","year":"2021","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.04.014","article-title":"Modulation of CXCR1 and CXCR3 expression on NK cells via TIM-3 in a murine model of primary biliary cholangitis","volume":"135","author":"Xu","year":"2021","journal-title":"Mol Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"19705","DOI":"10.1038\/s41598-021-99314-9","article-title":"Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis","volume":"11","author":"Kitahata","year":"2021","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.715852","article-title":"The microbiome in autoimmune liver diseases: metagenomic and metabolomic changes","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Physiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.616853","article-title":"Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases","volume":"12","author":"Gianchecchi","year":"2021","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13166","article-title":"Imbalanced distribution of group 2 innate lymphoid cells (ILCs) and ILC precursors in peripheral blood of patients with primary biliary cholangitis","volume":"96","author":"Li","year":"2022","journal-title":"Scand J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.631743","article-title":"Therapies targeting trained immune cells in inflammatory and autoimmune diseases","volume":"11","author":"Municio","year":"2021","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102956","article-title":"Involvement of trained immunity during autoimmune responses","volume":"137","author":"Mora","year":"2023","journal-title":"J Autoimmun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03176-0","article-title":"The effects of low-dose IL-2 on Th17\/Treg cell imbalance in primary biliary cholangitis mouse models","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2023.100188","article-title":"PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales","volume":"6","author":"Colapietro","year":"2023","journal-title":"J Transl Autoimmun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181580","article-title":"Current landscape and evolving therapies for primary biliary cholangitis","volume":"13","author":"Fiorucci","year":"2024","journal-title":"Cells"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1327973","article-title":"Deconvolution analysis identified altered hepatic cell landscape in primary sclerosing cholangitis and primary biliary cholangitis","volume":"11","author":"Pham","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2A0622-586RRRR","article-title":"IL-17A produced by invariant natural killer T cells and CD3+ CD56+ \u03b1Galcer-CD1d tetramer- T cells promote liver fibrosis in patients with primary biliary cholangitis","volume":"112","author":"Jia","year":"2022","journal-title":"J Leukoc Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1055\/a-2104-9034","article-title":"Mast cell and innate immune cell communication in cholestatic liver disease","volume":"43","author":"Bernard","year":"2023","journal-title":"Semin Liver Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2023.02.012","article-title":"Panic at the bile duct: how intrahepatic cholangiocytes respond to stress and injury","volume":"193","author":"Hrncir","year":"2023","journal-title":"Am J Pathol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-020-04765-2","article-title":"A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia","volume":"36","author":"Chusilp","year":"2020","journal-title":"Pediatr Surg Int"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32405","article-title":"Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis","volume":"76","author":"Mayo","year":"2022","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1192840","article-title":"Cholangiokines: undervalued modulators in the hepatic microenvironment","volume":"14","author":"Cai","year":"2023","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6890423","article-title":"MicroRNA-34a promotes EMT and liver fibrosis in primary biliary cholangitis by regulating TGF-\u03b21\/smad pathway","volume":"2021","author":"Pan","year":"2021","journal-title":"J Immunol Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21580","article-title":"Curcumin mitigates the epithelial-to-mesenchymal transition in biliary epithelial cells through upregulating CD109 expression","volume":"80","author":"Fan","year":"2019","journal-title":"Drug Dev Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13230","article-title":"Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-\u03baB in human biliary epithelial cells","volume":"31","author":"Kim","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24206","article-title":"Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis","volume":"53","author":"Chu","year":"2011","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2024.102512","article-title":"A heterogeneous subtype of biliary epithelial senescence may be involved in the pathogenesis of primary biliary cholangitis","volume":"49","author":"Sasaki","year":"2025","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102106","article-title":"An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis","volume":"47","author":"Sasaki","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3340","article-title":"Mesenchymal stem cells enhance autophagy of human intrahepatic biliary epithelial cells in vitro","volume":"36","author":"Zhu","year":"2018","journal-title":"Cell Biochem Funct"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.240.269","article-title":"Interleukin-17A-induced epithelial-mesenchymal transition of human intrahepatic biliary epithelial cells: implications for primary biliary cirrhosis","volume":"240","author":"Huang","year":"2016","journal-title":"Tohoku J Exp Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000611","article-title":"Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1","volume":"79","author":"Zhuang","year":"2024","journal-title":"Hepatology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16547","article-title":"Innate lymphoid cell subsets in the pathogenesis of primary biliary cholangitis","volume":"39","author":"Liu","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/cells12232725","article-title":"Bile acids in autoimmune liver disease: unveiling the nexus of inflammation, inflammatory cells, and treatment strategies","volume":"12","author":"Zhou","year":"2023","journal-title":"Cells"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000156","article-title":"Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survival","volume":"7","author":"\u00d6zdirik","year":"2023","journal-title":"Hepatol Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1023\/a:1020511002025","article-title":"Cytokine profile in the liver of primary biliary cirrhosis","volume":"19","author":"Nagano","year":"1999","journal-title":"J Clin Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"507","DOI":"10.21037\/atm-21-5448","article-title":"The gut microbiome contributes to splenomegaly and tissue inflammation in a murine model of primary biliary cholangitis","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/nu17071097","article-title":"Acylcarnitine and free fatty acid profiles in primary biliary cholangitis: associations with fibrosis and inflammation","volume":"17","author":"Rogalska","year":"2025","journal-title":"Nutrients"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290423","article-title":"Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44\/p42 mitogen-activated protein kinase","volume":"29","author":"Park","year":"1999","journal-title":"Hepatology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07165-1","article-title":"Downregulation of programmed death-1 pathway promoting CD8\u2009+\u2009T cell cytotoxicity in primary biliary cholangitis","volume":"67","author":"Zhang","year":"2022","journal-title":"Dig Dis Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-022-01713-1","article-title":"Fenofibrate downregulates NF-\u03baB signaling to inhibit pro-inflammatory cytokine secretion in human THP-1 macrophages and during primary biliary cholangitis","volume":"45","author":"Gallucci","year":"2022","journal-title":"Inflammation"},{"key":"B81","doi-asserted-by":"publisher","first-page":"389","DOI":"10.21037\/atm.2019.07.100","article-title":"The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis","volume":"7","author":"Sun","year":"2019","journal-title":"Ann Transl Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","article-title":"Hepatic IL-17 responses in human and murine primary biliary cirrhosis","volume":"32","author":"Lan","year":"2009","journal-title":"J Autoimmun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxad107","article-title":"IL-21, not IL-17A, exacerbates murine primary biliary cholangitis","volume":"215","author":"Chan","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29603","article-title":"Genetic association studies and the risk factors for developing the \u201cImmuno-bile-logic\u201d disease primary biliary cholangitis","volume":"67","author":"Liaskou","year":"2018","journal-title":"Hepatology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-024-05029-6","article-title":"Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome","volume":"22","author":"Yang","year":"2024","journal-title":"J Transl Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020605","article-title":"Soluble herpes virus entry mediator and type II\/III interferons are upregulated in primary biliary cholangitis","volume":"26","author":"Chung","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.014","article-title":"NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis","volume":"77","author":"Huang","year":"2022","journal-title":"J Hepatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.885229","article-title":"Concentration of serum matrix metalloproteinase-3 in patients with primary biliary cholangitis","volume":"13","author":"Bauer","year":"2022","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23906","article-title":"Estrogen receptor alpha-mediated mitochondrial damage in intrahepatic bile duct epithelial cells leading to the pathogenesis of primary biliary cholangitis","volume":"38","author":"Liang","year":"2023","journal-title":"Environ Toxicol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041745","article-title":"The mediating role of circulating inflammatory cytokines in causal associations between plasma metabolites and asymptomatic bile duct and cholecyst calculus: A Mendelian randomization study","volume":"104","author":"Peng","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247798","article-title":"Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma","volume":"16","author":"Saab","year":"2021","journal-title":"PloS One"},{"key":"B93","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/MOG.0000000000000910","article-title":"Intestinal microbiota in biliary diseases","volume":"39","author":"Xia","year":"2023","journal-title":"Curr Opin Gastroenterol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cgh.2022.09.006","article-title":"Bile duct colonization with enterococcus sp. Associates with disease progression in primary sclerosing cholangitis","volume":"21","author":"Zigmond","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/cphy.c130016","article-title":"Bile proteome in health and disease","volume":"4","author":"Farina","year":"2014","journal-title":"Compr Physiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i2.357","article-title":"Secondary bile acids and the biliary epithelia: The good and the bad","volume":"29","author":"Lenci","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00408","article-title":"Targeting gut microbiota for the treatment of primary biliary cholangitis: from bench to bedside","volume":"11","author":"Zhang","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnab038","article-title":"Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis","volume":"368","author":"Lammert","year":"2021","journal-title":"FEMS Microbiol Lett"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1362933","article-title":"Intestinal microbiota and biliary system diseases","volume":"14","author":"Wang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5985.23.03590-8","article-title":"Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway","volume":"70","author":"Abenavoli","year":"2024","journal-title":"Minerva Gastroenterol (Torino)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122355","article-title":"Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury","volume":"337","author":"Lu","year":"2024","journal-title":"Life Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110128","article-title":"RIPK2 as a promising druggable target for autoimmune diseases","volume":"118","author":"Zhao","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13075-021-02507-w","article-title":"Application of systems biology-based in silico tools to optimize treatment strategy identification in Still\u2019s disease","volume":"23","author":"Seg\u00fa-Verg\u00e9s","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"6","DOI":"10.56305\/001c.127836","article-title":"Biliary dyskinesia with reduced gallbladder ejection fraction: A diagnostic and therapeutic shift in management","volume":"4","author":"Elaskandrany","year":"2025","journal-title":"J Brown Hosp Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2024.100277","article-title":"Nutritional modulation of host defense peptide synthesis: A novel host-directed antimicrobial therapeutic strategy","volume":"15","author":"Whitmore","year":"2024","journal-title":"Adv Nutr"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113810","article-title":"Gut microbiota: A new insight into lung diseases","volume":"155","author":"Ma","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071694","article-title":"Network proximity-based drug repurposing strategy for early and late stages of primary biliary cholangitis","volume":"10","author":"Shahini","year":"2022","journal-title":"Biomedicines"},{"key":"B108","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/hep.32102","article-title":"Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4\/6 inhibitors in biliary tract cancers","volume":"75","author":"Arora","year":"2022","journal-title":"Hepatology"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189238","article-title":"Exosomes as a therapeutic strategy in cancer: potential roles as drug carriers and immune modulators","volume":"1880","author":"Abedi","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1042\/BST20230727","article-title":"Suppression of double-stranded RNA sensing in cancer: molecular mechanisms and therapeutic potential","volume":"52","author":"Young","year":"2024","journal-title":"Biochem Soc Trans"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1177\/2040622321993442","article-title":"Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges","volume":"12","author":"He","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.933565","article-title":"Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives","volume":"10","author":"Yang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01746","article-title":"hUCMSCs mitigate LPS-induced trained immunity in ischemic stroke","volume":"11","author":"Feng","year":"2020","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.599058","article-title":"Mesenchymal-stem-cell-derived extracellular vesicles mitigate trained immunity in the brain","volume":"8","author":"Feng","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10082033","article-title":"Update on the pharmacological treatment of primary biliary cholangitis","volume":"10","author":"Floreani","year":"2022","journal-title":"Biomedicines"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2025.0953","article-title":"Primary biliary cholangitis: a summary of pathogenesis and therapies","volume":"38","author":"Jallouli","year":"2025","journal-title":"Ann Gastroenterol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100377","article-title":"Stem cell membrane-camouflaged targeted delivery system in tumor","volume":"16","author":"Zhang","year":"2022","journal-title":"Mater Today Bio"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.597858","article-title":"Peripheral immune cell ratios and clinical outcomes in seropositive autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortium","volume":"11","author":"Broadley","year":"2021","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.638312","article-title":"Inflammatory markers predict survival in patients with advanced gastric and colorectal cancers receiving anti-PD-1 therapy","volume":"9","author":"Fan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratisl Lek Listy"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.754958","article-title":"Prognostic value of the systemic immune-inflammation index and prognostic nutritional index in patients with medulloblastoma undergoing surgical resection","volume":"8","author":"Zhu","year":"2021","journal-title":"Front Nutr"},{"key":"B122","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12876-022-02328-4","article-title":"Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy","volume":"22","author":"Mai","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12882-022-03020-1","article-title":"Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis","volume":"23","author":"Liao","year":"2022","journal-title":"BMC Nephrol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221148913","article-title":"Prognostic value of inflammatory and nutritional markers for patients with early-stage poorly-to moderately-differentiated cervical squamous cell carcinoma","volume":"30","author":"Guo","year":"2023","journal-title":"Cancer Control"},{"key":"B125","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12885-023-10889-0","article-title":"Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model","volume":"23","author":"Duan","year":"2023","journal-title":"BMC Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.3171\/2024.2.FOCUS2421","article-title":"The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma","volume":"56","author":"Hoppe","year":"2024","journal-title":"Neurosurg Focus"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S476346","article-title":"Development and validation of an inflammation-combined prognostic index (ICPI)-based nomogram for predicting overall survival in gastric cancer","volume":"17","author":"Li","year":"2024","journal-title":"J Inflammation Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S508019","article-title":"Predictive value of complete blood count indicators for short-term mortality in patients with combined coronary artery disease and chronic kidney disease","volume":"18","author":"An","year":"2025","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2023.104598","article-title":"Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness","volume":"150","author":"Garc\u00eda-Escobar","year":"2023","journal-title":"Microvasc Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"31369","DOI":"10.1038\/s41598-024-82854-1","article-title":"Development and external validation of an early prediction model to identify irresponsive patients and prognosis of UDCA treatment in primary biliary cholangitis","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084321","article-title":"Exploring advanced therapies for primary biliary cholangitis: insights from the gut microbiota-bile acid-immunity network","volume":"25","author":"Guo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.713647","article-title":"The salivary microbiota of patients with primary biliary cholangitis is distinctive and pathogenic","volume":"12","author":"Lv","year":"2021","journal-title":"Front Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1946366","article-title":"Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis","volume":"13","author":"Li","year":"2021","journal-title":"Gut Microbes"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.21.07316-X","article-title":"Fenofibrate improves GLOBE and UK-PBC scores and histological features in primary biliary cholangitis","volume":"113","author":"Wang","year":"2022","journal-title":"Minerva Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.2103","article-title":"Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid","volume":"6","author":"Ding","year":"2022","journal-title":"Hepatol Commun"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1342119","article-title":"Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study","volume":"11","author":"Yang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137553","article-title":"Hypoxia-inducible factors and innate immunity in liver cancer","volume":"130","author":"Yuen","year":"2020","journal-title":"J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(25)00091-8","article-title":"Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study","volume":"7","author":"Hagen","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1461102","article-title":"CAR immunotherapy in autoimmune diseases: promises and challenges","volume":"15","author":"Yu","year":"2024","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103350","article-title":"Advances in chimeric antigen receptor T cell therapy for autoimmune and autoinflammatory diseases and their complications","volume":"150","author":"Zeng","year":"2025","journal-title":"J Autoimmun"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00240-6","article-title":"Barriers to CAR T-cell therapy in rheumatology","volume":"7","author":"Lungova","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jaci.2024.12.1066","article-title":"Chimeric antigen receptor-modified T-cell therapy: Recent updates and challenges in autoimmune diseases","volume":"155","author":"Ca\u00ebl","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1533254","article-title":"Advance in chimeric antigen receptor T therapy in autoimmune diseases","volume":"16","author":"Ji","year":"2025","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1465191","article-title":"Application of novel CAR technologies to improve treatment of autoimmune disease","volume":"15","author":"Cheever","year":"2024","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-024-00692-z","article-title":"CAR T-cell therapy for rheumatic diseases: what does the future hold","volume":"39","author":"Avouac","year":"2025","journal-title":"BioDrugs"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102596","article-title":"Chimeric antigen receptor T cell therapy for autoimmune diseases","volume":"95","author":"Nie","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2391\u20132405","DOI":"10.1016\/j.ymthe.2025.01.035","article-title":"Engineering resilient CAR T cells for immunosuppressive environment","volume":"33","author":"Khalifeh","year":"2025","journal-title":"Mol Ther"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-022-2212-5","article-title":"CARs: a new approach for the treatment of autoimmune diseases","volume":"66","author":"Sun","year":"2023","journal-title":"Sci China Life Sci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2024.07.005","article-title":"Frontiers in CAR-T cell therapy for autoimmune diseases","volume":"45","author":"Li","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01139-z","article-title":"Advancements and challenges in CAR T cell therapy in autoimmune diseases","volume":"20","author":"Schett","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","article-title":"The TIM3\/Gal9 signaling pathway: An emerging target for cancer immunotherapy","volume":"510","author":"Kandel","year":"2021","journal-title":"Cancer Lett"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00097.2017","article-title":"Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation","volume":"314","author":"Gehrke","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/09727531211070532","article-title":"Role of JAK\/STAT in the neuroinflammation and its association with neurological disorders","volume":"28","author":"Jain","year":"2021","journal-title":"Ann Neurosci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112271","article-title":"Research progress of cGAS-STING signaling pathway in intestinal diseases","volume":"135","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1184252","article-title":"Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00940-w","article-title":"Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease","volume":"44","author":"Richardson","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31724","article-title":"Enoxacin up-regulates microRNA biogenesis and down-regulates cytotoxic CD8 T-cell function in autoimmune cholangitis","volume":"74","author":"Itoh","year":"2021","journal-title":"Hepatology"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103473","article-title":"Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis","volume":"156","author":"Hebbandi Nanjundappa","year":"2025","journal-title":"J Autoimmun"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103027","article-title":"Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis","volume":"136","author":"Yamashita","year":"2023","journal-title":"J Autoimmun"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00025-1","article-title":"Primary biliary cholangitis and the narrowing gap towards optimal disease control","volume":"10","author":"Can\u00e7ado","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004559","article-title":"Biopolymer immune implants\u2019 Sequential activation of innate and adaptive immunity for colorectal cancer postoperative immunotherapy","volume":"33","author":"Ji","year":"2021","journal-title":"Adv Mater"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107063","article-title":"IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities","volume":"201","author":"He","year":"2024","journal-title":"Pharmacol Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101037","article-title":"Investigating shared genetic architecture between inflammatory bowel diseases and primary biliary cholangitis","volume":"6","author":"Huang","year":"2024","journal-title":"JHEP Rep"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2024.100260","article-title":"Dissecting the genetic basis and mechanisms underlying the associations between multiple extrahepatic factors and autoimmune liver diseases","volume":"10","author":"Zhang","year":"2024","journal-title":"J Transl Autoimmun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655287\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:30:45Z","timestamp":1759383045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655287\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":164,"alternative-id":["10.3389\/fimmu.2025.1655287"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1655287","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1655287"}}